Menu Close
  • Clinical
    • In the Literature
    • Key Clinical Questions
    • Interpreting Diagnostic Tests
    • Coding Corner
    • Clinical
    • Clinical Guidelines
    • COVID-19
    • POCUS
  • Practice Management
    • Quality
    • Public Policy
    • How We Did It
    • Key Operational Question
    • Technology
    • Practice Management
  • Diversity
  • Career
    • Leadership
    • Education
    • Movers and Shakers
    • Career
    • Learning Portal
    • The Hospital Leader Blog
  • Pediatrics
  • HM Voices
    • Commentary
    • In Your Eyes
    • In Your Words
  • SHM Resources
    • Society of Hospital Medicine
    • Journal of Hospital Medicine
    • SHM Career Center
    • SHM Converge
    • Join SHM
    • Converge Coverage
    • SIG Spotlight
    • Chapter Spotlight
    • #JHM Chat
  • Industry Content
    • Patient Monitoring with Tech
An Official Publication of
  • Clinical
    • In the Literature
    • Key Clinical Questions
    • Interpreting Diagnostic Tests
    • Coding Corner
    • Clinical
    • Clinical Guidelines
    • COVID-19
    • POCUS
  • Practice Management
    • Quality
    • Public Policy
    • How We Did It
    • Key Operational Question
    • Technology
    • Practice Management
  • Diversity
  • Career
    • Leadership
    • Education
    • Movers and Shakers
    • Career
    • Learning Portal
    • The Hospital Leader Blog
  • Pediatrics
  • HM Voices
    • Commentary
    • In Your Eyes
    • In Your Words
  • SHM Resources
    • Society of Hospital Medicine
    • Journal of Hospital Medicine
    • SHM Career Center
    • SHM Converge
    • Join SHM
    • Converge Coverage
    • SIG Spotlight
    • Chapter Spotlight
    • #JHM Chat
  • Industry Content
    • Patient Monitoring with Tech

Addiction Medicine

  • Article

    Breaking News: X-waiver Eliminated

    January 25, 2023

    On January 12, 2023, the U.S. Drug Enforcement Administration (DEA) and the Substance Abuse and Mental Health Services Administration (SAMHSA) announced the immediate elimination of the X-waiver for...

  • Article

    How Do You Address Ongoing In-hospital Substance Use Among Adults with SUD?

    October 3, 2022

    Case A 28-year-old man with a past medical history notable for severe opioid use disorder and aortic valve endocarditis requiring valve replacement was admitted with recurrent bacteremia, prosthetic...

  • Article

    Recognizing and Treating Substance Use in the Inpatient Setting

    July 1, 2022

    Presenters: Erin McKnight, MD, MPH, Nationwide Children’s Hospital, Columbus, Ohio, Hilary Lin, MD, Children’s Health Orange County, Orange County, Calif., Stephanie Kwon, DO, Medical University...

  • Article

    New HHS Guidance for Increasing Number of Buprenorphine Clinicians Who Can Treat OUD

    June 1, 2022

    Does your state allow it? The ongoing opioid epidemic  The U.S. hit a grim milestone of more than 100,000 drug overdose deaths,1 most opioid-involved, in the 12 months ending April 2021. This...

  • Article

    Interpretation of the Urine Drug Screen

    May 2, 2022

    Dr. Cunningham Case A 40-year-old male with depression, post-traumatic stress disorder, and chronic pain presents with somnolence and a respiratory rate of 10 breaths per minute that responded to...

  • Article

    Inpatient addiction-medicine consultation services decrease 90-day mortality and seven-day readmission rates, but not 30-day readmission rates or ED utilization

    April 1, 2022

    Dr. Munoa Clinical question: Do inpatient addiction-medicine consultation services (AMCS) affect patient mortality and medical utilization post-discharge? Background:  AMCS are increasingly...

  • Article

    Characteristics of hospitalized patients whose substance use increased amid the impacts of COVID-19

    March 3, 2022

    Nearly 20 million U.S. adults experience a substance use disorder (SUD) annually,1 leading to more than 650 thousand hospital admissions.2 Large-scale crises like the COVID-19 pandemic can...

  • 1
    News

    Short-acting opioids needed for withdrawal in U.S. hospitals, say experts

    November 23, 2021

    The short-acting drugs can complement methadone and buprenorphine to help patients get faster relief and help patients stay in the hospital to help with long-term management, say the authors of a new commentary.

  • 1
    News

    U.S. overdose deaths hit an all-time high

    November 18, 2021

    Fentanyl and methamphetamine are contributing to rising numbers of fatalities, federal officials say.

  • 1
    News

    FDA approves combo pill for severe, acute pain

    October 19, 2021

    Seglentis contains 56 mg of celecoxib and 44 mg of tramadol.

Previous1 2 3 4 5 … 13Next
  • About The Hospitalist
  • Contact Us
  • The Editors
  • Editorial Board
  • Authors
  • Publishing Opportunities
  • Subscribe
  • Advertise
fa-facebookfa-linkedinfa-instagramfa-youtube-playfa-commentfa-envelopefa-rss
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies.
    ISSN 1553-085X
  • Privacy Policy
  • Terms and Conditions
  • SHM’s DE&I Statement
  • Cookie Preferences